QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety
Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the treatment effect of QL1203 in combination with
mFOLFOX6 compared to Placebo in combination with mFOLFOX6 as first line therapy for
metastatic colorectal cancer.